Marshall J Glesby, MD, PHD

Photos

53 W 23rd St Fl 6
New York, NY 10010
Dr. Marshall Glesby is Associate Chief of the Division of Infectious Diseases and Director of the Cornell HIV Clinical Trials Unit at the Weill Cornell Medical College. He is a graduate of the Johns Hopkins University School of Medicine and completed his internal medicine residency and infectious diseases fellowship at the Johns Hopkins Hospital. He also has a Ph.D. in Clinical Investigation from the Johns Hopkins School of Hygiene and Public Health and is board certified in internal medicine and infectious diseases. Dr. Glesby's primary research focus is metabolic complications of HIV disease and its therapy. He is active in the NIH-sponsored AIDS Clinical Trials Group (ACTG) and has served as Vice Chair of their Hepatitis Committee and a member of the ACTG Scientific Agenda Steering Committee. He is also the Regional Clinical Director of the federally funded New York/New Jersey AIDS Education and Training Center (AETC) and the medical director of the Weill Cornell AETC site of this consortium. Dr. Glesby co-directs the Clinical Trials Design and Analysis course of the Weill Cornell K30 funded Masters in Clinical Investigation program. He serves on the Weill Cornell Clinical & Translational Science Center's Adult Translational Research Advisory Committee and their Multidisciplinary Institutional Advisory Committee. He is an Assistant Editor of the Journal of Acquired Immune Deficiency Syndromes. He also serves on the Weill Cornell Data Safety Monitoring Board (DSMB) and was a member of the Food and Drug Administration's Antiviral Drugs Advisory Committee.
Owner verified
See a problem?

You might also like

Kristen Marks, M.D.
Internal medicine practitioners

Kristen Marks, M.D.

Dr. Marks is an Associate Professor of Medicine at Weill Cornell Medicine (WCM) where she conducts clinical trials related to HIV, HCV and COVID prevention and treatment. She received Internal Medicine residency and Infectious Diseases fellowship training at New York-Presbyterian Hospital (Cornell), where she focused clinical training and research on HIV and hepatitis virus infections and completed Weill Cornell's Master's Degree in Clinical Investigation.She hastaken a leadership role advancing the treatment of HIV and hepatitis C in underserved populations at Cornell through clinical, education, and research activities.Her current research focuses on improving treatment outcomes in patients with HIV and hepatitis virus co-infections. Several research projects have focused specifically on people who inject drugs including an ongoing R01-funded study comparing HCV treatment delivery at a community syringe exchange program with usual care.She isthe co-chair of an AIDS Clinical Trials Group (ACTG) multi-center study to assesses a novel Hepatitis B vaccine, currently serve on three ACTG protocol teams, andis a member of the ACTG Hepatitis Transformative Science Group.She servesas a co-director of the Cornell HIV/AIDS Clinical Trials Unit, where she conductsseveral treatment studiesrelated to HIV and hepatitis viruses. Sheserved as co-chair of IDSA/AASLDs joint guidelines panel for Recommendations for testing, managing and treating hepatitis C and as a member of New York States HCV guidelines panel. When the COVID pandemic hit New York City,she led the phase 3 studies of remdesivir at Weill Cornell as well as a phase 3 studiesof avaccinefor the prevention of COVID.
United StatesNew YorkNew YorkMarshall J Glesby, MD, PHD

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.